PHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2018
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2018 |
| Quarter | 4 Qtr |
| Quarterly report for the financial period ended | 31 Dec 2018 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
31 Dec 2018
|
31 Dec 2017
|
31 Dec 2018
|
31 Dec 2017
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
596,644
|
613,196
|
2,384,956
|
2,323,960
|
| 2 | Profit/(loss) before tax |
11,940
|
19,866
|
70,220
|
73,064
|
| 3 | Profit/(loss) for the period |
4,570
|
22,088
|
43,230
|
55,087
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
4,437
|
21,700
|
42,468
|
53,823
|
| 5 | Basic earnings/(loss) per share (Subunit) |
1.71
|
8.36
|
16.33
|
20.74
|
| 6 | Proposed/Declared dividend per share (Subunit) |
2.00
|
6.00
|
16.00
|
19.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.9600
|
2.0300
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 21 Feb 2019 |
| Category | Financial Results |
| Reference Number | FRA-20022019-00003 |